Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
- PMID: 36820211
- PMCID: PMC9938539
- DOI: 10.1515/biol-2022-0553
Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
Abstract
Currently, there is no consensus on whether maintenance dialysis increases cancer risk in patients with end-stage renal disease (ESRD). Therefore, this study was to systematically evaluate the risk of cancer among ESRD patients undergoing maintenance dialysis. Related studies on the impact of maintenance dialysis on cancer risk were retrieved from PubMed, Embase, Cochrane Library, and other databases from their respective inceptions to 19 February 2021. ESRD patients receiving maintenance dialysis were classified into cancer including non-melanoma skin cancer (NMSC) and cancer excluding NMSC. Standardized incidence ratio (SIR) with its 95% confidence interval (95% CI) was calculated to assess cancer risk. Fourteen studies were included in the meta-analysis. The risk of cancer in patients undergoing maintenance dialysis (with or without NMSC) was significantly higher than controls both in cancer including NMSC (SIR = 1.38, 95% CI: 1.27-1.49, P < 0.001) and cancer excluding NMSC (SIR = 1.34, 95% CI: 1.23-1.47, P < 0.001). Subgroup results identified the higher risk of cancer incidence in both men and women receiving maintenance dialysis. Meanwhile, elevated excess risks were observed among patients with younger age and shorter follow-up time (P < 0.001). Meanwhile, the combined SIR of bladder, cervix, colorectum, kidney, liver, thyroid, tongue, and other cancers were all increased (P < 0.05). ESRD patients undergoing dialysis has higher risk of cancer.
Keywords: cancer incidence; maintenance dialysis; meta-analysis.
© 2023 the author(s), published by De Gruyter.
Conflict of interest statement
Conflict of interest: Authors state no conflict of interest.
Figures



Similar articles
-
Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.Mol Clin Oncol. 2016 Sep;5(3):315-325. doi: 10.3892/mco.2016.952. Epub 2016 Jul 7. Mol Clin Oncol. 2016. PMID: 27602224 Free PMC article.
-
Italian cancer figures, report 2013: Multiple tumours.Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. Epidemiol Prev. 2013. PMID: 24259384 English, Italian.
-
Incidence of major urological cancers in patients on dialysis: a systematic review and meta-analysis.World J Surg Oncol. 2025 Apr 4;23(1):118. doi: 10.1186/s12957-025-03763-9. World J Surg Oncol. 2025. PMID: 40186281 Free PMC article.
-
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.J Am Soc Nephrol. 2003 Jan;14(1):197-207. doi: 10.1097/01.asn.0000039608.81046.81. J Am Soc Nephrol. 2003. PMID: 12506152
-
Comparison Between Hemodialysis and Peritoneal Dialysis in the Risks for Disease Activity in LN-ESRD Patients: A Systematic Review and Meta-analysis.Altern Ther Health Med. 2022 Sep;28(6):144-149. Altern Ther Health Med. 2022. PMID: 35648699
Cited by
-
Cancer before and after the start of hemodialysis and association with mortality - an Eastern-European multicenter study.Ren Fail. 2023 Dec;45(1):2232046. doi: 10.1080/0886022X.2023.2232046. Ren Fail. 2023. PMID: 37439202 Free PMC article.
-
Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort.Sci Rep. 2024 Aug 30;14(1):20154. doi: 10.1038/s41598-024-71041-x. Sci Rep. 2024. PMID: 39215076 Free PMC article.
-
Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology.J Nephrol. 2025 Jun;38(5):1369-1379. doi: 10.1007/s40620-024-02102-7. Epub 2024 Oct 15. J Nephrol. 2025. PMID: 39404957 Free PMC article. Review.
References
-
- Lisowska KA, Storoniak H, Dębska-Ślizień A. T cell subpopulations and cytokine levels in hemodialysis patients. Hum Immunol. 2022;83(2):134–43. - PubMed
LinkOut - more resources
Full Text Sources